Inappropriate ICD Shocks From Rapid Atrial Fibrillation
64-year-old man with prior anterior MI and an ICD for secondary prevention receives three shocks while awake at home. He feels palpitations and lightheadedness but no syncope. BP 112/70. ECG shows atrial fibrillation with a ventricular rate of 170–190 bpm and no evidence of VT. Device interrogation shows shocks delivered for rates above the VF detection zone; stored electrograms show rapid, irregular atrial fibrillation with variable ventricular conduction, not ventricular tachycardia. He is on metoprolol succinate 50 mg daily and apixaban 5 mg twice daily. Potassium 4.0, magnesium 1.8, creatinine 1.1.
1. Why did the ICD fire, and what immediate device and medical management do you recommend?
Read the worked answer
The shocks were inappropriate. The device classified rapid AF with variable ventricular conduction as VF because the ventricular rate crossed the programmed VF detection threshold; the stored electrograms show irregular RR intervals and no organized ventricular tachycardia.
Immediate steps: disable shock therapy or reprogram to monitor-only while the patient is monitored; treat the AF with rate control (intravenous metoprolol or diltiazem if LV function permits; avoid verapamil/diltiazem if EF is severely reduced); correct electrolytes; evaluate for precipitating illness. Do not simply increase the detection rate without also using SVT discriminators (onset, stability, morphology) and ensuring the patient is monitored. Continue anticoagulation. If he is hemodynamically stable, cardioversion can be considered after ensuring adequate anticoagulation; if unstable, urgent cardioversion. The key judgment is to prevent further inappropriate shocks without leaving him unprotected from true VT/VF.
2. How would you prevent recurrence and address his stroke risk? Include rhythm versus rate control and catheter ablation.
Read the worked answer
Stroke risk: AF with prior MI and an ICD gives a CHA2DS2-VASc score of at least 2; continue apixaban indefinitely unless bleeding. Verify dose: 5 mg twice daily is appropriate if he has no dose-reduction criteria (age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL).
Rate control: beta-blocker first; target resting HR <100–110 if asymptomatic, stricter if symptoms persist.
Rhythm control: catheter ablation is reasonable for symptomatic AF, especially if rate control fails or if tachycardia-mediated cardiomyopathy is suspected. Antiarrhythmic drugs: avoid sotalol/dofetilide if QT risk is a concern; amiodarone can be used but has toxicity; flecainide/propafenone are contraindicated with structural heart disease. Device reprogramming: higher VF detection rate, SVT discriminators, and morphology criteria. If AF is paroxysmal and ablation is chosen, continue anticoagulation according to stroke risk, not rhythm status.